Skip to main content
. 2022 Mar 11;9:836862. doi: 10.3389/fmolb.2022.836862

TABLE 3.

CT scores of patients in each lung lobe.

Early stage Progressive and peak stage Absorption stage
Right upper lobe Delta Variant 0.5 ± 0.5 (0–2) 0.8 ± 0.6 (0–3) 0.7 ± 0.7 (0–3)
Original COVID-19 0.8 ± 0.7 (0–1) 1.0 ± 0.4 (0–2) 0.6 ± 0.6 (0–2)
Right middle lobe Delta Variant 0.5 ± 0.5 (0–2) 0.8 ± 0.7 (0–4) 0.6 ± 0.7 (0–4)*
Original COVID-19 0.5 ± 0.5 (0–1) 0.8 ± 0.7 (0–2) 0.3 ± 0.4 (0–1)*
Right lower lobe Delta Variant 0.8 ± 0.6 (0–2)* 1.2 ± 0.9 (0–4) 0.9 ± 0.8 (0–4)
Original COVID-19 1.3 ± 0.6 (0–2)* 1.4 ± 0.5 (1–2) 0.8 ± 0.7 (0–3)
Left upper lobe Delta Variant 0.7 ± 0.4 (0–2) 1.0 ± 0.7 (0–4) 0.9 ± 0.8 (0–4)*
Original COVID-19 0.6 ± 0.5 (0–1) 0.6 ± 0.4 (0–1) 0.5 ± 0.5 (0–2)*
Left lower lobe Delta Variant 1.2 ± 0.8 (0–4) 1.4 ± 0.8 (0–4) 1.2 ± 0.9 (0–4)
Original COVID-19 1.4 ± 0.5 (1–2) 1.3 ± 0.6 (0–2) 1.1 ± 0.7 (0–4)

Data are means ± standard deviations, with ranges in parentheses.

*Represents significant difference obtained by Mann–Whitney U test (p < 0.05).